| A Study Designed to Evaluate Tear Production (NCT06544707) | Alcon Research | 2024-10-15 |
| Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy (NCT06679270) | Chiesi Farmaceutici S.p.A. | 2024-10-14 |
| Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS). (NCT07184684) | Region Skane | 2024-10-14 |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis (NCT06632444) | Boehringer Ingelheim | 2024-10-14 |
| Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (NCT06023459) | Yih-Ing Hser | 2024-10-14 |
| FocaL Mass Drug Administration for Vivax Malaria Elimination (NCT05690841) | University of California, San Francisco | 2024-10-14 |
| Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) (NCT06553768) | Mirum Pharmaceuticals, Inc. | 2024-10-14 |
| Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A (NCT06643819) | Chong Kun Dang Pharmaceutical | 2024-10-14 |
| Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation (NCT06565247) | Region Västerbotten | 2024-10-14 |
| Study of the Use of Methoxyflurane vs Placebo in the Management of Pain in Oral and Dental Emergencies in Adults: METODO (METhoxyflurane in ODOntology) (NCT06495372) | University Hospital, Brest | 2024-10-14 |
| A Strain Change Study for SARS-CoV-2 rS Vaccines (NCT06409663) | Novavax | 2024-10-14 |
| Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations (NCT06640465) | OvationLab | 2024-10-12 |
| Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer (NCT06757621) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-10-10 |
| A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) (NCT06516952) | Incyte Corporation | 2024-10-10 |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III) (NCT06081244) | Women's Cancer Study Group GmbH | 2024-10-10 |
| Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT06578949) | Alexion Pharmaceuticals, Inc. | 2024-10-10 |
| Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis (NCT06615726) | Capital Medical University | 2024-10-10 |
| Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries (NCT06424834) | Stanford University | 2024-10-10 |
| A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) (NCT06516965) | Incyte Corporation | 2024-10-10 |
| Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema (NCT07515079) | Bio-Thera Solutions | 2024-10-09 |
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) (NCT05417789) | SynOx Therapeutics Limited | 2024-10-09 |
| Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia (NCT06643416) | Queen Mary Hospital, Hong Kong | 2024-10-09 |
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 (NCT06630286) | Gilead Sciences | 2024-10-09 |
| Pancreatic Cancer Diagnosis With FAPI-PET Imaging (NCT07098598) | Turku University Hospital | 2024-10-09 |
| Colon Cancer Diagnosis With FAPI-PET Imaging (NCT07272772) | Turku University Hospital | 2024-10-09 |
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 (NCT06630299) | Gilead Sciences | 2024-10-08 |
| Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus (NCT05028140) | EMS | 2024-10-08 |
| The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients (NCT06503016) | Università Vita-Salute San Raffaele | 2024-10-08 |
| A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease (NCT06544694) | Alcon Research | 2024-10-08 |
| Clinical of Hypersensitivity Reduction Efficacy on Two Toothpastes (NCT06937697) | Colgate Palmolive | 2024-10-08 |
| To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis (NCT06552520) | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 2024-10-08 |
| Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant (NCT06701396) | Vanda Pharmaceuticals | 2024-10-08 |
| An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis (NCT06540144) | UCB Biopharma SRL | 2024-10-08 |
| Effect of Finerenone in IgA Nephropathy (NCT06580288) | Zhejiang University | 2024-10-08 |
| A Study of TAK-861 in People With Narcolepsy Type 1 (NCT06505031) | Takeda | 2024-10-08 |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% (NCT06561386) | Bristol-Myers Squibb | 2024-10-07 |
| An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations (NCT06538662) | Alcon Research | 2024-10-07 |
| A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea (NCT06593587) | Pfizer | 2024-10-07 |
| Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR (NCT06376916) | Wake Forest University Health Sciences | 2024-10-07 |
| Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging (NCT06276465) | UNICANCER | 2024-10-07 |
| A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort (NCT06492174) | Boston Scientific Corporation | 2024-10-07 |
| Efficacy of INM004 in Children With STEC-HUS (NCT06389474) | Inmunova S.A. | 2024-10-05 |
| A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT06417814) | AstraZeneca | 2024-10-04 |
| Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease (NCT06274554) | Weill Medical College of Cornell University | 2024-10-04 |
| A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients (NCT06578078) | Fundación para la Investigación del Hospital Clínico de Valencia | 2024-10-03 |
| Can PLIA Reduce Early Post-operative Pain After PAO Surgery? (NCT06519955) | Michael C Willey | 2024-10-03 |
| A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis (NCT06596772) | mAbxience Research S.L. | 2024-10-03 |
| Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) (NCT06643117) | Formycon AG | 2024-10-03 |
| REDucing Hot FLASHes in Women Using Endocrine Therapy. (NCT06106529) | Reinier de Graaf Groep | 2024-10-03 |
| REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities (NCT06399705) | Weill Medical College of Cornell University | 2024-10-02 |
| Vitiligo, New Treatment and Serum s100B (NCT06768840) | South Valley University | 2024-10-02 |
| A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) (NCT06597344) | GlaxoSmithKline | 2024-10-02 |
| Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma (NCT06561048) | Corvus Pharmaceuticals, Inc. | 2024-10-02 |
| Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer (NCT06539091) | Anhui Provincial Hospital | 2024-10-01 |
| The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD (NCT06474039) | Mahidol University | 2024-10-01 |
| Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention (NCT06550804) | University of Illinois at Chicago | 2024-10-01 |
| Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery (NCT06617897) | CSL Behring | 2024-10-01 |
| Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Ttransanal Endoscopic Microsurgery in T1 N0, M0 Rectal Cancer (TAUTEM-T1 Study) (NCT06450574) | Corporacion Parc Tauli | 2024-10-01 |
| Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza (NCT06528444) | Instituto de Investigación Sanitaria y Biomédica de Alicante | 2024-10-01 |
| A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD) (NCT06614725) | GlaxoSmithKline | 2024-10-01 |
| Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer (NCT06542549) | Anhui Provincial Hospital | 2024-10-01 |
| A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks. (NCT06602284) | Equipmed USA LLC | 2024-10-01 |
| RSV Vaccine in Transplant Recipients (NCT06593210) | University Health Network, Toronto | 2024-10-01 |
| Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy (NCT06628908) | Vertex Pharmaceuticals Incorporated | 2024-10-01 |
| Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section (NCT06010368) | Cairo University | 2024-10-01 |
| A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer (NCT06545955) | Ferring Pharmaceuticals | 2024-10-01 |
| Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab (NCT06614387) | JAROSLAW KIERKUS | 2024-10-01 |
| Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke (NCT05484154) | ZZ Biotech, LLC | 2024-10-01 |
| Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer (NCT06097416) | St. James's Hospital, Ireland | 2024-10-01 |
| Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2) (NCT06677970) | Yonsei University | 2024-10-01 |
| Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. (NCT06506955) | Taiho Oncology, Inc. | 2024-10-01 |
| Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial (NCT06267300) | Erasmus Medical Center | 2024-10-01 |
| Primary Care dySpEpsia rikkuNshiTo (NCT06482671) | Universitaire Ziekenhuizen KU Leuven | 2024-10-01 |
| Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer (NCT06510374) | Ferring Pharmaceuticals | 2024-10-01 |
| Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion (NCT07229456) | Ain Shams University | 2024-10-01 |
| Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients (NCT06620393) | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 2024-10-01 |
| Therapeutic Effect of Manuka Honey Oral Rinse in Periodontitis Patients Undergoing Hemodialysis (NCT06726876) | Ain Shams University | 2024-10-01 |
| Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block (NCT06899841) | Assiut University | 2024-10-01 |
| Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection (NCT07279792) | Ain Shams University | 2024-10-01 |
| A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia (NCT06589817) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2024-10-01 |
| Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33) (NCT06273527) | University of California, San Diego | 2024-10-01 |
| Use of Iv Tramadol and Ketamine for Prevention of Post Spinal Anesthesia Shivering (NCT06722742) | Liaquat National Hospital & Medical College | 2024-09-30 |
| A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT06660992) | Haisco Pharmaceutical Group Co., Ltd. | 2024-09-30 |
| Twice-per-weekSelinexor, 2 Days Melphalan (NCT06613035) | Institute of Hematology & Blood Diseases Hospital, China | 2024-09-30 |
| Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context (NCT06428838) | Dr George Medvedev | 2024-09-30 |
| Effect of Genicular Arteries Embolization in Symptomatic Knee Osteoarthritis LipioJoint-2 (NCT06497140) | Assistance Publique - Hôpitaux de Paris | 2024-09-30 |
| The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients (NCT06509191) | Sultan Qaboos University | 2024-09-30 |
| A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R (NCT06717360) | Ahn-Gook Pharmaceuticals Co.,Ltd | 2024-09-30 |
| Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight (NCT06588283) | Eli Lilly and Company | 2024-09-30 |
| A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer (NCT06526624) | Hansoh BioMedical R&D Company | 2024-09-30 |
| Clinical Efficacy of the Combined Effect of Oral Irrigator and Chemicals (0.075% CPC) (NCT06607172) | Colgate Palmolive | 2024-09-30 |
| Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (NCT06473779) | AstraZeneca | 2024-09-30 |
| Phase III Presbyopia Correction Using the VIS Opti-K™ System (NCT06487897) | VIS, Inc. | 2024-09-30 |
| A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin (NCT06589765) | Shandong Suncadia Medicine Co., Ltd. | 2024-09-27 |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (NCT06492616) | Stemline Therapeutics, Inc. | 2024-09-27 |
| A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis (NCT06068465) | Tasly Pharmaceutical Group Co., Ltd | 2024-09-27 |
| Skin Care Regimen for Improving Photoaging Signs on the Face (NCT06603857) | Goldman, Butterwick, Fitzpatrick and Groff | 2024-09-27 |
| ACT-GLOBAL Adaptive Platform Trial for Stroke (NCT06352632) | The George Institute | 2024-09-26 |
| Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients (NCT06635447) | AstraZeneca | 2024-09-26 |
| A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer (NCT06755515) | Shandong New Time Pharmaceutical Co., LTD | 2024-09-26 |